Aspen Neuroscience, Inc. (ASPE) income statement
ASPEPharmaceutical PreparationsFiscal year ends December 31
$14.89+14.88 (+148800.00%)
Close on Oct 30, 2026Market cap –P/E –Yield –
Aspen Neuroscience, Inc. income statement
AnnualQuarterlyTTM
This company has not reported income statement data in its XBRL filings.
Ratios
Latest available
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY
- –
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –